Evaxion Biotech A/S (EVAX) DCF Valuation

Evaxion Biotech A/S (EVAX) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

Evaxion Biotech A/S (EVAX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Whether you're an investor or an analyst, this (EVAX) DCF Calculator is your essential tool for accurate valuation. Preloaded with real data from Evaxion Biotech A/S, you can adjust forecasts and observe the effects in real-time.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .1 .1 .1 .1 .1 .1
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -11.9 -16.5 -24.2 -22.6 -21.4 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 -29319.18 60 60 60 60 60
Depreciation .1 .1 .3 .6 .6 .1 .1 .1 .1 .1
Depreciation, % 100 100 100 100 843.76 100 100 100 100 100
EBIT -12.0 -16.6 -24.5 -23.2 -22.0 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 -30162.94 60 60 60 60 60
Total Cash 9.6 5.8 32.2 13.2 5.6 .1 .1 .1 .1 .1
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .9 .0 .0 .0 1.1
Account Receivables, % 100 100 100 100 1472.56
Inventories .0 -6.9 -1.9 -2.5 .0 .1 .1 .1 .1 .1
Inventories, % 100 100 100 100 0 80 80 80 80 80
Accounts Payable .6 3.7 2.8 2.1 2.7 .1 .1 .1 .1 .1
Accounts Payable, % 100 100 100 100 3683.56 100 100 100 100 100
Capital Expenditure -.1 -.4 -1.4 -.3 -.1 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 -119.18 -20 -20 -20 -20 -20
Tax Rate, % 3.45 3.45 3.45 3.45 3.45 3.45 3.45 3.45 3.45 3.45
EBITAT -11.2 -15.0 -24.3 -22.4 -21.3 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -11.4 -4.4 -31.2 -22.3 -23.7 -1.6 .1 .1 .1 .1
WACC, % 7.2 7.04 7.6 7.44 7.43 7.34 7.34 7.34 7.34 7.34
PV UFCF
SUM PV UFCF -1.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 2
Present Terminal Value 1
Enterprise Value 0
Net Debt 5
Equity Value -5
Diluted Shares Outstanding, MM 3
Equity Value Per Share -1.86

What You Will Get

  • Comprehensive EVAX Financials: Access to historical and projected data for precise valuation.
  • Customizable Parameters: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Real-Time Calculations: Dynamic calculations for intrinsic value and NPV.
  • Scenario Analysis: Evaluate various scenarios to assess Evaxion Biotech's future performance.
  • User-Friendly Interface: Designed for professionals while remaining approachable for newcomers.

Key Features

  • Comprehensive DCF Model: Features both unlevered and levered DCF valuation frameworks tailored for Evaxion Biotech A/S (EVAX).
  • WACC Estimator: Ready-to-use Weighted Average Cost of Capital calculator with adjustable parameters.
  • Customizable Forecast Inputs: Adjust growth projections, capital investments, and discount rates as needed.
  • Integrated Financial Metrics: Evaluate profitability, leverage, and efficiency ratios specifically for Evaxion Biotech A/S (EVAX).
  • Interactive Dashboard and Visuals: Graphical representations that highlight essential valuation indicators for straightforward assessment.

How It Works

  • 1. Download the Template: Obtain and open the Excel file containing Evaxion Biotech A/S's preloaded data.
  • 2. Adjust Assumptions: Modify essential inputs such as growth rates, WACC, and capital expenditures.
  • 3. Analyze Results Immediately: The DCF model automatically computes intrinsic value and NPV based on your inputs.
  • 4. Explore Scenarios: Evaluate various forecasts to understand different valuation possibilities.
  • 5. Present with Assurance: Deliver professional valuation insights to enhance your decision-making process.

Why Choose This Calculator for Evaxion Biotech A/S (EVAX)?

  • Precision: Utilizes real Evaxion financial data for enhanced accuracy.
  • Versatility: Allows users to easily test and adjust inputs as needed.
  • Efficiency: Eliminate the need to create a DCF model from the ground up.
  • Expert-Level: Crafted with the precision and usability expected by CFOs.
  • Intuitive: Simple to navigate, suitable for users without extensive financial modeling skills.

Who Should Use This Product?

  • Investors: Accurately estimate Evaxion Biotech A/S’s (EVAX) fair value before making investment decisions.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis related to Evaxion Biotech A/S (EVAX).
  • Consultants: Quickly tailor the template for valuation reports for clients interested in Evaxion Biotech A/S (EVAX).
  • Entrepreneurs: Acquire insights into financial modeling practices employed by leading biotech firms, including Evaxion Biotech A/S (EVAX).
  • Educators: Employ it as a teaching resource to illustrate valuation methodologies relevant to the biotech sector, including Evaxion Biotech A/S (EVAX).

What the Template Contains

  • Preloaded EVAX Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.